Total amount: € 0,00
Online ISSN 1827-1596
Castillo-Zamora C. 1, Del Carmen Lespron M. 2, Nava-Ocampo A. A. 3
1 Department of Anesthesia Hospital Infantil de México Federico Gómez Secretaría de Salud, México
2 Department of Anesthesia Instituto Nacional de Cardiología ''Ignacio Chávez'', Secretaría de Salud, México
3 Department of Clinical Pharmacology Hospital Infantil de México Federico Gómez Secretaría de Salud, México
Aim. Rocuronium may be a good alternative to pancuronium in cardiac surgical patients. We evaluate the hemodynamic response to rocuronium and pancuronium administered to cardiac surgical patients.
Methods. A single-blind, randomized clinical trial was carried out at the National Institute of Cardiology in Mexico. Twenty-two patients older than 18 years, NYHA class III-IV, and scheduled to undergo an elective cardiovascular surgical procedure were enrolled. Patients were randomly allocated to receive an i.v. bolus dose of either pancuronium 100 µg/kg or rocuronium 600 µg/kg. Peripheral arterial (radial) and venous cannulations and insertion of a multi-lumen pulmonary artery flotation catheter through the right internal jugular vein were carried out under local anesthesia. Anesthetic induction with an i.v. bolus dose of fentanyl 700 µg and diazepam 20 mg was performed and thereafter the neuromuscular blocking agent was administered. Ventilation with O2 100% was performed until a TOF ≤5% was observed and tracheal intubation was performed. After intubation, patients were maintained with O2 10 mL/kg administered by means of a pulmonary ventilator at a pressure of 20-25 cm H2O. The basal, pre-laryngoscopy, post-intubation, and pre-operative recording of a set of cardiovascular parameters were obtained.
Results. No differences (P>0.05) in the hemodynamic response were observed between pancuronium and rocuronium nor during the different evaluation times in each group.
Conclusion. Rocuronium can be a safe alternative to pancuronium for patients requiring cardiac surgical procedures.